Motus GI files for $29M initial public offering — 3 insights

Motus GI Holdings, a medical device company, filed a $29 million initial public offering with the Securities Exchange Commission Jan. 5, Renaissance Capital reports.

Advertisement

Here’s what you should know:

1. Motus was founded in 2008. It plans to list on the Nasdaq under the symbol MOTS.

2. Piper Jaffray and Oppenheimer & Co. served as the joint bookrunners.

3. Motus initiated the filing on April 12, 2017.

More article on gastroenterology:
Top 10 states with the highest volume of gastroenterology procedures per ASC
GI leader to know: Dr. Christopher Brown of Atlanta Gastroenterology Associates
Northside Park Gastroenterology and Endoscopy Center owner Dr. Michael Sue to retire — 4 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.